HEADER MEMBRANE PROTEIN 15-APR-25 9UIM TITLE CRYO-EM STRUCTURE OF THE HUMAN CB1 CANNABINOID RECEPTOR BOUND TO THE TITLE 2 INVERSE AGONIST TARANABANT RESOLVED VIA THE FUSION/CROSSLINKING TITLE 3 STRATEGY COMPND MOL_ID: 1; COMPND 2 MOLECULE: CANNABINOID RECEPTOR 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CB-R,CB1,CANN6; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: GREEN FLUORESCENT PROTEIN; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 3; COMPND 11 MOLECULE: GFP-CLAMP E186C; COMPND 12 CHAIN: C; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CNR1, CNR; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: AEQUOREA VICTORIA; SOURCE 10 ORGANISM_TAXID: 6100; SOURCE 11 GENE: GFP; SOURCE 12 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 14 MOL_ID: 3; SOURCE 15 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 16 ORGANISM_TAXID: 32630; SOURCE 17 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS HUMAN CB1 CANNABINOID RECEPTOR; FUSION/CROSSLINKING STRATEGY; KEYWDS 2 TARANABANT., MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR S.C.HAN,M.H.LI REVDAT 1 28-OCT-26 9UIM 0 JRNL AUTH S.C.HAN,M.H.LI JRNL TITL CRYO-EM STRUCTURE DETERMINATION OF GPCRS WITH JRNL TITL 2 DISULFIDE-CROSSLINKED FUSION PROTEIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.06 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : RELION, PHENIX, RELION REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.060 REMARK 3 NUMBER OF PARTICLES : 270609 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9UIM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 18-APR-25. REMARK 100 THE DEPOSITION ID IS D_1300058571. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CB1-GFP10-11:GFP1-9:GFP-CLAMP REMARK 245 E186C COMPLEX BOUND TO REMARK 245 TARANABANT REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 SUMMIT (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2200.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 97 REMARK 465 ARG A 98 REMARK 465 GLY A 99 REMARK 465 GLU A 100 REMARK 465 GLU A 106 REMARK 465 CYS A 107 REMARK 465 PHE A 108 REMARK 465 MET A 109 REMARK 465 VAL A 110 REMARK 465 LEU A 111 REMARK 465 ASN A 112 REMARK 465 PRO A 413 REMARK 465 SER A 414 REMARK 465 MET B 1 REMARK 465 GLY B 2 REMARK 465 THR B 3 REMARK 465 ARG B 4 REMARK 465 GLY B 191 REMARK 465 ASP B 192 REMARK 465 GLY B 193 REMARK 465 PRO B 194 REMARK 465 VAL B 195 REMARK 465 LEU B 196 REMARK 465 LEU B 197 REMARK 465 PRO B 198 REMARK 465 GLY C 158 REMARK 465 GLY C 159 REMARK 465 GLY C 160 REMARK 465 SER C 161 REMARK 465 GLY C 162 REMARK 465 GLY C 163 REMARK 465 GLY C 164 REMARK 465 ASP C 165 REMARK 465 ALA C 293 REMARK 465 ALA C 294 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY B 53 N - CA - C ANGL. DEV. = 26.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 219 -7.16 72.55 REMARK 500 ARG A 220 59.46 -156.74 REMARK 500 ASP B 105 -168.71 -160.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 VAL C 152 -10.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-64197 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF THE HUMAN CB1 CANNABINOID RECEPTOR BOUND TO REMARK 900 THE INVERSE AGONIST TARANABANT RESOLVED VIA THE FUSION/CROSSLINKING REMARK 900 STRATEGY DBREF 9UIM A 99 301 UNP P21554 CNR1_HUMAN 99 301 DBREF 9UIM A 341 414 UNP P21554 CNR1_HUMAN 341 414 DBREF1 9UIM B 4 198 UNP A0A059PIQ0_AEQVI DBREF2 9UIM B A0A059PIQ0 2 196 DBREF 9UIM C 1 294 PDB 9UIM 9UIM 1 294 SEQADV 9UIM GLY A 97 UNP P21554 EXPRESSION TAG SEQADV 9UIM ARG A 98 UNP P21554 EXPRESSION TAG SEQADV 9UIM ALA A 210 UNP P21554 THR 210 CONFLICT SEQADV 9UIM CYS A 222 UNP P21554 LEU 222 CONFLICT SEQADV 9UIM LYS A 273 UNP P21554 GLU 273 CONFLICT SEQADV 9UIM VAL A 283 UNP P21554 THR 283 CONFLICT SEQADV 9UIM ARG A 1001 UNP P21554 LINKER SEQADV 9UIM ARG A 1002 UNP P21554 LINKER SEQADV 9UIM GLN A 1003 UNP P21554 LINKER SEQADV 9UIM LEU A 1004 UNP P21554 LINKER SEQADV 9UIM GLY A 1005 UNP P21554 LINKER SEQADV 9UIM HIS A 1006 UNP P21554 LINKER SEQADV 9UIM TYR A 1007 UNP P21554 LINKER SEQADV 9UIM LEU A 1008 UNP P21554 LINKER SEQADV 9UIM SER A 1009 UNP P21554 LINKER SEQADV 9UIM THR A 1010 UNP P21554 LINKER SEQADV 9UIM GLN A 1011 UNP P21554 LINKER SEQADV 9UIM THR A 1012 UNP P21554 LINKER SEQADV 9UIM SER A 1013 UNP P21554 LINKER SEQADV 9UIM LEU A 1014 UNP P21554 LINKER SEQADV 9UIM SER A 1015 UNP P21554 LINKER SEQADV 9UIM LYS A 1016 UNP P21554 LINKER SEQADV 9UIM ASP A 1017 UNP P21554 LINKER SEQADV 9UIM LEU A 1018 UNP P21554 LINKER SEQADV 9UIM ASN A 1019 UNP P21554 LINKER SEQADV 9UIM GLU A 1020 UNP P21554 LINKER SEQADV 9UIM LYS A 1021 UNP P21554 LINKER SEQADV 9UIM ARG A 1022 UNP P21554 LINKER SEQADV 9UIM ASP A 1023 UNP P21554 LINKER SEQADV 9UIM HIS A 1024 UNP P21554 LINKER SEQADV 9UIM MET A 1025 UNP P21554 LINKER SEQADV 9UIM VAL A 1026 UNP P21554 LINKER SEQADV 9UIM LEU A 1027 UNP P21554 LINKER SEQADV 9UIM LEU A 1028 UNP P21554 LINKER SEQADV 9UIM GLU A 1029 UNP P21554 LINKER SEQADV 9UIM PHE A 1030 UNP P21554 LINKER SEQADV 9UIM VAL A 1031 UNP P21554 LINKER SEQADV 9UIM THR A 1032 UNP P21554 LINKER SEQADV 9UIM ALA A 1033 UNP P21554 LINKER SEQADV 9UIM ALA A 1034 UNP P21554 LINKER SEQADV 9UIM GLY A 1035 UNP P21554 LINKER SEQADV 9UIM LEU A 1036 UNP P21554 LINKER SEQADV 9UIM GLN A 1037 UNP P21554 LINKER SEQADV 9UIM LYS A 1038 UNP P21554 LINKER SEQADV 9UIM GLU A 1039 UNP P21554 LINKER SEQADV 9UIM ILE A 339 UNP P21554 LINKER SEQADV 9UIM GLU A 340 UNP P21554 LINKER SEQADV 9UIM MET B 1 UNP A0A059PIQ INITIATING METHIONINE SEQADV 9UIM GLY B 2 UNP A0A059PIQ EXPRESSION TAG SEQADV 9UIM THR B 3 UNP A0A059PIQ EXPRESSION TAG SEQADV 9UIM ILE B 18 UNP A0A059PIQ VAL 16 CONFLICT SEQADV 9UIM ARG B 32 UNP A0A059PIQ SER 30 CONFLICT SEQADV 9UIM TYR B 41 UNP A0A059PIQ ASN 39 CONFLICT SEQADV 9UIM CRO B 68 UNP A0A059PIQ THR 65 CONFLICT SEQADV 9UIM B UNP A0A059PIQ TYR 66 DELETION SEQADV 9UIM B UNP A0A059PIQ GLY 67 DELETION SEQADV 9UIM SER B 74 UNP A0A059PIQ ALA 72 CONFLICT SEQADV 9UIM ARG B 82 UNP A0A059PIQ GLN 80 CONFLICT SEQADV 9UIM TYR B 101 UNP A0A059PIQ SER 99 CONFLICT SEQADV 9UIM MET B 155 UNP A0A059PIQ THR 153 CONFLICT SEQADV 9UIM ASN B 160 UNP A0A059PIQ LYS 158 CONFLICT SEQRES 1 A 320 GLY ARG GLY GLU ASN PHE MET ASP ILE GLU CYS PHE MET SEQRES 2 A 320 VAL LEU ASN PRO SER GLN GLN LEU ALA ILE ALA VAL LEU SEQRES 3 A 320 SER LEU THR LEU GLY THR PHE THR VAL LEU GLU ASN LEU SEQRES 4 A 320 LEU VAL LEU CYS VAL ILE LEU HIS SER ARG SER LEU ARG SEQRES 5 A 320 CYS ARG PRO SER TYR HIS PHE ILE GLY SER LEU ALA VAL SEQRES 6 A 320 ALA ASP LEU LEU GLY SER VAL ILE PHE VAL TYR SER PHE SEQRES 7 A 320 ILE ASP PHE HIS VAL PHE HIS ARG LYS ASP SER ARG ASN SEQRES 8 A 320 VAL PHE LEU PHE LYS LEU GLY GLY VAL THR ALA SER PHE SEQRES 9 A 320 THR ALA SER VAL GLY SER LEU PHE LEU ALA ALA ILE ASP SEQRES 10 A 320 ARG TYR ILE SER ILE HIS ARG PRO CYS ALA TYR LYS ARG SEQRES 11 A 320 ILE VAL THR ARG PRO LYS ALA VAL VAL ALA PHE CYS LEU SEQRES 12 A 320 MET TRP THR ILE ALA ILE VAL ILE ALA VAL LEU PRO LEU SEQRES 13 A 320 LEU GLY TRP ASN CYS GLU LYS LEU GLN SER VAL CYS SER SEQRES 14 A 320 ASP ILE PHE PRO HIS ILE ASP LYS THR TYR LEU MET PHE SEQRES 15 A 320 TRP ILE GLY VAL VAL SER VAL LEU LEU LEU PHE ILE VAL SEQRES 16 A 320 TYR ALA TYR MET TYR ILE LEU TRP LYS ALA ARG ARG GLN SEQRES 17 A 320 LEU GLY HIS TYR LEU SER THR GLN THR SER LEU SER LYS SEQRES 18 A 320 ASP LEU ASN GLU LYS ARG ASP HIS MET VAL LEU LEU GLU SEQRES 19 A 320 PHE VAL THR ALA ALA GLY LEU GLN LYS GLU ILE GLU LEU SEQRES 20 A 320 ALA LYS THR LEU VAL LEU ILE LEU VAL VAL LEU ILE ILE SEQRES 21 A 320 CYS TRP GLY PRO LEU LEU ALA ILE MET VAL TYR ASP VAL SEQRES 22 A 320 PHE GLY LYS MET ASN LYS LEU ILE LYS THR VAL PHE ALA SEQRES 23 A 320 PHE CYS SER MET LEU CYS LEU LEU ASN SER THR VAL ASN SEQRES 24 A 320 PRO ILE ILE TYR ALA LEU ARG SER LYS ASP LEU ARG HIS SEQRES 25 A 320 ALA PHE ARG SER MET PHE PRO SER SEQRES 1 B 196 MET GLY THR ARG LYS GLY GLU GLU LEU PHE THR GLY VAL SEQRES 2 B 196 VAL PRO ILE LEU ILE GLU LEU ASP GLY ASP VAL ASN GLY SEQRES 3 B 196 HIS LYS PHE SER VAL ARG GLY GLU GLY GLU GLY ASP ALA SEQRES 4 B 196 THR TYR GLY LYS LEU THR LEU LYS PHE ILE CYS THR THR SEQRES 5 B 196 GLY LYS LEU PRO VAL PRO TRP PRO THR LEU VAL THR THR SEQRES 6 B 196 LEU CRO VAL GLN CYS PHE SER ARG TYR PRO ASP HIS MET SEQRES 7 B 196 LYS ARG HIS ASP PHE PHE LYS SER ALA MET PRO GLU GLY SEQRES 8 B 196 TYR VAL GLN GLU ARG THR ILE TYR PHE LYS ASP ASP GLY SEQRES 9 B 196 THR TYR LYS THR ARG ALA GLU VAL LYS PHE GLU GLY ASP SEQRES 10 B 196 THR LEU VAL ASN ARG ILE GLU LEU LYS GLY ILE ASP PHE SEQRES 11 B 196 LYS GLU ASP GLY ASN ILE LEU GLY HIS LYS LEU GLU TYR SEQRES 12 B 196 ASN PHE ASN SER HIS ASN VAL TYR ILE MET ALA ASP LYS SEQRES 13 B 196 GLN ASN ASN GLY ILE LYS ALA ASN PHE LYS ILE ARG HIS SEQRES 14 B 196 ASN VAL GLU ASP GLY SER VAL GLN LEU ALA ASP HIS TYR SEQRES 15 B 196 GLN GLN ASN THR PRO ILE GLY ASP GLY PRO VAL LEU LEU SEQRES 16 B 196 PRO SEQRES 1 C 294 ASP LEU GLY LYS LYS LEU LEU GLU ALA ALA ARG ALA GLY SEQRES 2 C 294 GLN ASP ASP GLU VAL ARG ILE LEU MET ALA ASN GLY ALA SEQRES 3 C 294 ASP VAL ASN ALA ALA ASP ASP VAL GLY VAL THR PRO LEU SEQRES 4 C 294 HIS LEU ALA ALA GLN ARG GLY HIS LEU GLU ILE VAL GLU SEQRES 5 C 294 VAL LEU LEU LYS TYR GLY ALA ASP VAL ASN ALA ALA ASP SEQRES 6 C 294 LEU TRP GLY GLN THR PRO LEU HIS LEU ALA ALA THR ALA SEQRES 7 C 294 GLY HIS LEU GLU ILE VAL GLU VAL LEU LEU LYS ASN GLY SEQRES 8 C 294 ALA ASP VAL ASN ALA ARG ASP ASN ILE GLY HIS THR PRO SEQRES 9 C 294 LEU HIS LEU ALA ALA TRP ALA GLY HIS LEU GLU ILE VAL SEQRES 10 C 294 GLU VAL LEU LEU LYS TYR GLY ALA ASP VAL ASN ALA GLN SEQRES 11 C 294 ASP LYS PHE GLY LYS THR PRO PHE ASP LEU ALA ILE ASP SEQRES 12 C 294 ASN GLY ASN GLU ASP ILE ALA GLU VAL LEU GLN LYS ALA SEQRES 13 C 294 ALA GLY GLY GLY SER GLY GLY GLY ASP VAL ASN ALA TYR SEQRES 14 C 294 ASP GLU VAL GLY TRP THR PRO LEU HIS LYS ALA ALA TRP SEQRES 15 C 294 GLY HIS LEU CYS LYS VAL GLU ASP LEU LEU LYS ASN GLY SEQRES 16 C 294 ALA ASP VAL ASN ALA ALA ASP ILE ASP GLY TYR THR PRO SEQRES 17 C 294 LEU HIS LEU ALA ALA PHE SER GLY HIS LEU GLU ILE VAL SEQRES 18 C 294 GLU VAL LEU LEU LYS TYR GLY ALA ASP VAL ASN ALA ASP SEQRES 19 C 294 ASP GLN ALA GLY PHE THR PRO LEU HIS LEU ALA ALA ILE SEQRES 20 C 294 PHE GLY HIS LEU GLU ILE VAL GLU VAL LEU LEU LYS ASN SEQRES 21 C 294 GLY ALA ASP VAL ASN ALA GLN ASP LYS PHE GLY LYS THR SEQRES 22 C 294 PRO PHE ASP LEU ALA ILE ASP ASN GLY ASN GLU ASP ILE SEQRES 23 C 294 ALA GLU VAL LEU GLN LYS ALA ALA MODRES 9UIM CRO B 68 THR CHROMOPHORE MODRES 9UIM CRO B 68 TYR CHROMOPHORE MODRES 9UIM CRO B 68 GLY CHROMOPHORE HET CRO B 68 22 HET 7DY A1101 36 HETNAM CRO {2-[(1R,2R)-1-AMINO-2-HYDROXYPROPYL]-4-(4- HETNAM 2 CRO HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-1- HETNAM 3 CRO YL}ACETIC ACID HETNAM 7DY N-[(2S,3S)-4-(4-CHLOROPHENYL)-3-(3-CYANOPHENYL)BUTAN-2- HETNAM 2 7DY YL]-2-METHYL-2-{[5-(TRIFLUOROMETHYL)PYRIDIN-2- HETNAM 3 7DY YL]OXY}PROPANAMIDE HETSYN CRO PEPTIDE DERIVED CHROMOPHORE FORMUL 2 CRO C15 H17 N3 O5 FORMUL 4 7DY C27 H25 CL F3 N3 O2 HELIX 1 AA1 SER A 114 SER A 144 1 31 HELIX 2 AA2 SER A 144 CYS A 149 1 6 HELIX 3 AA3 ARG A 150 SER A 152 5 3 HELIX 4 AA4 TYR A 153 VAL A 179 1 27 HELIX 5 AA5 SER A 185 ILE A 218 1 34 HELIX 6 AA6 ALA A 223 VAL A 228 1 6 HELIX 7 AA7 THR A 229 VAL A 249 1 21 HELIX 8 AA8 LEU A 250 GLY A 254 5 5 HELIX 9 AA9 ASN A 256 GLN A 261 1 6 HELIX 10 AB1 ASP A 272 LYS A 300 1 29 HELIX 11 AB2 GLU A 1039 PHE A 368 1 31 HELIX 12 AB3 ASN A 372 SER A 401 1 30 HELIX 13 AB4 SER A 401 PHE A 412 1 12 HELIX 14 AB5 GLY B 6 THR B 11 5 6 HELIX 15 AB6 PRO B 58 VAL B 63 5 6 HELIX 16 AB7 PRO B 77 ASP B 84 5 8 HELIX 17 AB8 LEU C 2 GLY C 13 1 12 HELIX 18 AB9 GLN C 14 ASN C 24 1 11 HELIX 19 AC1 THR C 37 GLY C 46 1 10 HELIX 20 AC2 HIS C 47 TYR C 57 1 11 HELIX 21 AC3 THR C 70 GLY C 79 1 10 HELIX 22 AC4 HIS C 80 LYS C 89 1 10 HELIX 23 AC5 THR C 103 GLY C 112 1 10 HELIX 24 AC6 HIS C 113 TYR C 123 1 11 HELIX 25 AC7 THR C 136 ASN C 144 1 9 HELIX 26 AC8 ASN C 146 ALA C 157 1 12 HELIX 27 AC9 THR C 175 ALA C 181 1 7 HELIX 28 AD1 HIS C 184 GLY C 195 1 12 HELIX 29 AD2 THR C 207 GLY C 216 1 10 HELIX 30 AD3 HIS C 217 TYR C 227 1 11 HELIX 31 AD4 THR C 240 GLY C 249 1 10 HELIX 32 AD5 HIS C 250 ASN C 260 1 11 HELIX 33 AD6 THR C 273 GLY C 282 1 10 HELIX 34 AD7 GLU C 284 LYS C 292 1 9 SHEET 1 AA112 HIS A1006 SER A1015 0 SHEET 2 AA112 HIS A1024 ALA A1034 -1 O ALA A1034 N TYR A1007 SHEET 3 AA112 LYS B 43 CYS B 50 -1 O PHE B 48 N MET A1025 SHEET 4 AA112 HIS B 27 ASP B 38 -1 N ARG B 32 O ILE B 49 SHEET 5 AA112 VAL B 13 VAL B 24 -1 N ILE B 16 O GLY B 35 SHEET 6 AA112 THR B 120 ILE B 130 1 O ASN B 123 N GLU B 19 SHEET 7 AA112 THR B 107 GLU B 117 -1 N ARG B 111 O GLU B 126 SHEET 8 AA112 TYR B 94 PHE B 102 -1 N GLN B 96 O ALA B 112 SHEET 9 AA112 VAL B 178 PRO B 189 -1 O THR B 188 N VAL B 95 SHEET 10 AA112 ILE B 163 ASN B 172 -1 N HIS B 171 O GLN B 179 SHEET 11 AA112 ASN B 151 ALA B 156 -1 N MET B 155 O LYS B 164 SHEET 12 AA112 HIS A1006 SER A1015 -1 N LEU A1008 O VAL B 152 SSBOND 1 CYS A 222 CYS C 186 1555 1555 2.05 SSBOND 2 CYS A 257 CYS A 264 1555 1555 2.04 LINK C LEU B 66 N1 CRO B 68 1555 1555 1.38 LINK C3 CRO B 68 N VAL B 70 1555 1555 1.38 CISPEP 1 MET B 90 PRO B 91 0 0.74 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 CONECT 902 5290 CONECT 1177 1231 CONECT 1231 1177 CONECT 2918 2924 CONECT 2924 2918 2925 CONECT 2925 2924 2926 2929 CONECT 2926 2925 2927 2928 CONECT 2927 2926 CONECT 2928 2926 CONECT 2929 2925 2930 2931 CONECT 2930 2929 2934 CONECT 2931 2929 2932 2935 CONECT 2932 2931 2933 2934 CONECT 2933 2932 CONECT 2934 2930 2932 2938 CONECT 2935 2931 2936 CONECT 2936 2935 2937 2946 CONECT 2937 2936 CONECT 2938 2934 2939 CONECT 2939 2938 2940 2941 CONECT 2940 2939 2942 CONECT 2941 2939 2943 CONECT 2942 2940 2944 CONECT 2943 2941 2944 CONECT 2944 2942 2943 2945 CONECT 2945 2944 CONECT 2946 2936 CONECT 5290 902 CONECT 6093 6094 6102 CONECT 6094 6093 6095 CONECT 6095 6094 6096 6100 CONECT 6096 6095 6097 6098 6099 CONECT 6097 6096 CONECT 6098 6096 CONECT 6099 6096 CONECT 6100 6095 6101 CONECT 6101 6100 6102 CONECT 6102 6093 6101 6103 CONECT 6103 6102 6104 CONECT 6104 6103 6105 6106 6107 CONECT 6105 6104 CONECT 6106 6104 CONECT 6107 6104 6108 6109 CONECT 6108 6107 CONECT 6109 6107 6110 CONECT 6110 6109 6111 6112 CONECT 6111 6110 CONECT 6112 6110 6113 6121 CONECT 6113 6112 6114 6120 CONECT 6114 6113 6115 CONECT 6115 6114 6116 6118 CONECT 6116 6115 6117 CONECT 6117 6116 CONECT 6118 6115 6119 CONECT 6119 6118 6120 CONECT 6120 6113 6119 CONECT 6121 6112 6122 CONECT 6122 6121 6123 6128 CONECT 6123 6122 6124 CONECT 6124 6123 6125 CONECT 6125 6124 6126 6127 CONECT 6126 6125 CONECT 6127 6125 6128 CONECT 6128 6122 6127 MASTER 195 0 2 34 12 0 0 6 6125 3 64 64 END